94 related articles for article (PubMed ID: 1312169)
1. Reversal of desipramine toxicity in rats using drug-specific antibody Fab' fragment: effects on hypotension and interaction with sodium bicarbonate.
Brunn GJ; Keyler DE; Pond SM; Pentel PR
J Pharmacol Exp Ther; 1992 Mar; 260(3):1392-9. PubMed ID: 1312169
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and mechanism of action of sodium bicarbonate in the treatment of desipramine toxicity in rats.
Pentel P; Benowitz N
J Pharmacol Exp Ther; 1984 Jul; 230(1):12-9. PubMed ID: 6086872
[TBL] [Abstract][Full Text] [Related]
3. Effects of specific antibody Fab fragments on desipramine pharmacokinetics in the rat in vivo and in the isolated, perfused liver.
Keyler DE; Le Couteur DG; Pond SM; St Peter JV; Pentel PR
J Pharmacol Exp Ther; 1995 Mar; 272(3):1117-23. PubMed ID: 7891324
[TBL] [Abstract][Full Text] [Related]
4. Reversal of desipramine toxicity in rats with polyclonal drug-specific antibody Fab fragments.
Pentel PR; Ross CA; Landon J; Sidki A; Shelver WL; Keyler DE
J Lab Clin Med; 1994 Mar; 123(3):387-93. PubMed ID: 8133150
[TBL] [Abstract][Full Text] [Related]
5. Drug-specific F(ab')2 fragment reduces desipramine cardiotoxicity in rats.
Brunn GJ; Keyler DE; Ross CA; Pond SM; Pentel PR
Int J Immunopharmacol; 1991; 13(7):841-51. PubMed ID: 1761350
[TBL] [Abstract][Full Text] [Related]
6. Reduction of desipramine cardiotoxicity and prolongation of survival in rats with the use of polyclonal drug-specific antibody Fab fragments.
Pentel PR; Scarlett W; Ross CA; Landon J; Sidki A; Keyler DE
Ann Emerg Med; 1995 Sep; 26(3):334-41. PubMed ID: 7661425
[TBL] [Abstract][Full Text] [Related]
7. Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal antibody: dose-response relationship.
Pentel PR; Keyler DE; Brunn GJ; Milavetz JM; Gilbertson DG; Matta SG; Pond SM
Drug Metab Dispos; 1991; 19(1):24-8. PubMed ID: 1673407
[TBL] [Abstract][Full Text] [Related]
8. Toxicity of high doses of polyclonal drug-specific antibody Fab fragments.
Keyler DE; Shelver WL; Landon J; Sidki A; Pentel PR
Int J Immunopharmacol; 1994 Dec; 16(12):1027-34. PubMed ID: 7705964
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment with drug-specific antibody reduces desipramine cardiotoxicity in rats.
Pentel PR; Brunn GJ; Pond SM; Keyler DE
Life Sci; 1991; 48(7):675-83. PubMed ID: 1990238
[TBL] [Abstract][Full Text] [Related]
10. Effects of high dose alpha-1-acid glycoprotein on desipramine toxicity in rats.
Pentel PR; Keyler DE
J Pharmacol Exp Ther; 1988 Sep; 246(3):1061-6. PubMed ID: 3418509
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide contributes to desipramine-induced hypotension in rats.
Pentel PR; Wananukul W; Scarlett W; Keyler DE
Hum Exp Toxicol; 1996 Apr; 15(4):320-8. PubMed ID: 8845222
[TBL] [Abstract][Full Text] [Related]
12. A pilot pharmacokinetic study of tricyclic antidepressant ovine Fab for TCA poisoning in children.
Yalindağ-Oztürk N; Goto CS; Shepherd G; Torres ON; Giroir B
Clin Toxicol (Phila); 2010 Jun; 48(5):418-23. PubMed ID: 20524830
[TBL] [Abstract][Full Text] [Related]
13. Tricyclic antidepressant-specific Fab fragments alter the distribution and elimination of desipramine in the rabbit: a model for overdose treatment.
Hursting MJ; Opheim KE; Raisys VA; Kenny MA; Metzger G
J Toxicol Clin Toxicol; 1989; 27(1-2):53-66. PubMed ID: 2769821
[TBL] [Abstract][Full Text] [Related]
14. What is the role of lidocaine or phenytoin in tricyclic antidepressant-induced cardiotoxicity?
Foianini A; Joseph Wiegand T; Benowitz N
Clin Toxicol (Phila); 2010 May; 48(4):325-30. PubMed ID: 20507243
[TBL] [Abstract][Full Text] [Related]
15. Drug-specific antibodies as antidotes for tricyclic antidepressant overdose.
Pentel PR; Keyler DE
Toxicol Lett; 1995 Dec; 82-83():801-6. PubMed ID: 8597145
[TBL] [Abstract][Full Text] [Related]
16. Studies on the contribution of putative anti-carbohydrate antibodies to the specificity of immunofluorescence staining of murine T cells with chicken anti-mouse (Fab')2 reagents.
Deluca D; Warr GW; Marchalonis JJ
J Immunol; 1982 Nov; 129(5):2025-32. PubMed ID: 6181155
[TBL] [Abstract][Full Text] [Related]
17. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
[TBL] [Abstract][Full Text] [Related]
18. Effect of calcium chloride and 4-aminopyridine therapy on desipramine toxicity in rats.
Wananukul W; Keyler DE; Pentel PR
J Toxicol Clin Toxicol; 1996; 34(5):499-506. PubMed ID: 8800187
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant drug-specific single chain antibody Fv fragment on [3H]-desipramine distribution in rats.
Shelver WL; Keyler DE; Lin G; Murtaugh MP; Flickinger MC; Ross CA; Pentel PR
Biochem Pharmacol; 1996 Feb; 51(4):531-7. PubMed ID: 8619899
[TBL] [Abstract][Full Text] [Related]
20. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro.
Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D
Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
